We are live on ! Find out more
KCM

Knoll Capital Management Portfolio holdings

AUM $180M
1-Year Est. Return 66.11%
This Fund
S&P 500
This Quarter Est. Return
+19.59%
1 Year Est. Return
+66.11%
3 Year Est. Return
+268.55%
5 Year Est. Return
+741%
10 Year Est. Return
+10,877.35%
AUM
$64.9M
AUM Growth
+$20.6M
Cap. Flow
+$15M
Cap. Flow %
23.18%
Top 10 Hldgs %
77.5%
Holding
29
New
8
Increased
6
Reduced
–
Closed
3

Top Buys

Rank Stock Value
1
VRNA
Verona Pharma
VRNA
+$2.26M
2
OR icon
OR Royalties Inc
OR
+$2.22M
3
OMGA
Omega Therapeutics, Inc. Common Stock
OMGA
+$1.2M
4
SILV
SilverCrest Metals Inc. Common Shares
SILV
+$1.04M
5
NOC icon
Northrop Grumman
NOC
+$1M

Top Sells

Rank Stock Value
1
AVDL
Avadel Pharmaceuticals
AVDL
+$1.23M
2
BX icon
Blackstone
BX
+$742K

Sector Composition

Rank Sector Weight
1 Healthcare 65.57%
2 Materials 6.74%
3 Industrials 3.4%
4 Financials 1.69%
5 Consumer Staples 1.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALDX icon
1
Aldeyra Therapeutics
ALDX
$91.7M
$20.5M 31.63%
2,067,160
+119,070
+6% +$842K
BHVN
2
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$6.15M 9.48%
450,422
– –
AVDL
3
CALL
DELISTED
Avadel Pharmaceuticals
AVDL
$4.58M 7.06%
+500,000
New +$4.11M
VRNA
4
DELISTED
Verona Pharma
VRNA
$4.02M 6.19%
200,000
+104,609
+110% +$2.26M
GDX icon
5
VanEck Gold Miners ETF
GDX
$23B
$2.97M 4.58%
91,850
– –
ENTX icon
6
Entera Bio
ENTX
$101M
$2.88M 4.44%
2,484,275
– –
APLT
7
DELISTED
Applied Therapeutics
APLT
$2.8M 4.31%
3,450,000
+1,000,000
+41% +$985K
SIL icon
8
Global X Silver Miners ETF NEW
SIL
$4.08B
$2.76M 4.25%
89,700
– –
GDXJ icon
9
VanEck Junior Gold Miners ETF
GDXJ
$7.06B
$2.1M 3.24%
53,150
– –
OCUL icon
10
Ocular Therapeutix
OCUL
$1.86B
$1.5M 2.32%
+200,000
New +$950K
OR icon
11
OR Royalties Inc
OR
$5.47B
$1.27M 1.96%
400,000
+165,000
+70% +$2.22M
TMO icon
12
Thermo Fisher Scientific
TMO
$211B
$1.21M 1.87%
2,100
– –
BAH icon
13
Booz Allen Hamilton
BAH
$8.7B
$1.2M 1.86%
13,000
– –
V icon
14
Visa
V
$677B
$1.09M 1.69%
4,850
– –
CVS icon
15
CVS Health
CVS
$137B
$1.08M 1.66%
14,500
– –
SILV
16
DELISTED
SilverCrest Metals Inc. Common Shares
SILV
$1.04M 1.61%
+170,000
New +$1.04M
OMGA
17
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
$1.04M 1.61%
+173,010
New +$1.2M
SA
18
Seabridge Gold
SA
$2.8B
$1.04M 1.6%
80,000
+39,000
+95% +$482K
FNV icon
19
Franco-Nevada
FNV
$41.4B
$1.02M 1.57%
+7,000
New +$976K
MO icon
20
Altria Group
MO
$122B
$1.01M 1.56%
22,700
– –
NOC icon
21
Northrop Grumman
NOC
$77B
$1,000K 1.54%
+2,165
New +$1M
ALT icon
22
Altimmune
ALT
$539M
$734K 1.13%
173,864
– –
OCUL icon
23
CALL
Ocular Therapeutix
OCUL
$1.86B
$505K 0.78%
+95,800
New +$455K
IRD
24
Opus Genetics
IRD
$254M
$375K 0.58%
+100,000
New +$359K
HOOK
25
DELISTED
HOOKIPA Pharma
HOOK
$221K 0.34%
30,000
+25,000
+500% +$224K
1
2

Similar funds

MGWA
Monument Group Wealth Advisors Concord, Massachusetts $180M AUM 19.81% 1-Year Est. Return
AW
Alchemi Wealth Essex, Connecticut $180M AUM
FBC
Fairfield, Bush & Co Darien, Connecticut $180M AUM 39.51% 1-Year Est. Return
AIC
Aurora Investment Counsel Atlanta, Georgia $180M AUM 0.3% 1-Year Est. Return
AG
Amiral Gestion Paris, France $180M AUM 9.43% 1-Year Est. Return
PCA
Prospect Capital Advisors Sausalito, California $180M AUM 60.99% 1-Year Est. Return
HIC
Hamrick Investment Counsel Seattle, Washington $180M AUM
FFA
Frazier Financial Advisors Columbus, Ohio $181M AUM 11.16% 1-Year Est. Return

Knoll Capital Management's Q1 2023 Portfolio in Review

As of Q1 2023, Knoll Capital Management held 29 positions worth $64.9M, up 46% from $44.3M the previous quarter. Its ten largest holdings account for 77% of the portfolio.

Knoll Capital Management deployed $15M of net new capital in Q1 2023, opening 8 new positions and adding to 6 existing holdings. Its largest new stake was Omega Therapeutics, Inc. Common Stock: 173,010 shares worth $1.04M.

By sector, the portfolio is most concentrated in Healthcare at 66% of assets, down from 69% a quarter earlier, followed by Materials and Industrials.

On the sell side, the most notable exit was Avadel Pharmaceuticals, an estimated $1.23M sold.

  • Knoll Capital Management's largest Q1 2023 buy was Omega Therapeutics, Inc. Common Stock: 173,010 shares worth $1.04M.
  • Knoll Capital Management added most to Verona Pharma in Q1 2023, an estimated $2.26M increase.
  • Knoll Capital Management fully exited Avadel Pharmaceuticals in Q1 2023, selling an estimated $1.23M.
  • Knoll Capital Management's ten largest holdings make up 77% of its $64.9M portfolio in Q1 2023.
  • Knoll Capital Management opened 8 new positions and closed 3 in Q1 2023.
  • Knoll Capital Management's portfolio value rose 46% quarter-over-quarter to $64.9M.

Based on Knoll Capital Management's 13F filing for Q1 2023, filed 15 May 2023.